ECOR
What one share of electroCore holds
Electromedical and Electrotherapeutic Apparatus
ElectroCore is a bioelectronic medicine and general wellness company dedicated to improving health and quality of life through our proprietary non-invasive vagus nerve stimulation (“nVNS”) technology platform and related product offerings.
electroCore’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.14 |
|---|---|
| Profit | −$1.66 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$1.09 |
| Cash and investments | $1.12 |
| Debt | $0.75 |
| Book value | −$0.31 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | $1.22 | −$23.05 | $0.04 | −$23.04 | — | $12.20 |
| 2020 | $1.34 | −$9.04 | — | −$7.71 | — | $7.58 |
| 2021 | $1.38 | −$4.36 | — | −$3.45 | — | $7.77 |
| 2022 | $1.82 | −$4.69 | — | −$3.52 | — | $3.60 |
| 2023 | $2.91 | −$3.42 | $0.04 | −$2.70 | — | $1.24 |
| 2024 | $3.37 | −$1.59 | — | −$0.93 | — | $1.13 |
| 2025 | $3.78 | −$1.65 | $0.01 | −$0.97 | — | −$0.21 |